Continuing to confront COPD international patient survey: Methods, COPD prevalence, and disease burden in 2012-2013

International Journal of COPD

Volumn 9, Issue , 2014, Pages 597-607

  Landis, Sarah H ^a   Muellerova, Hana ^a   Mannino, David M ^b   Menezes, Ana M ^c   Han, MeiLan K ^d   van der Molen, Thys ^e   Masakazu, Ichinose ^f   Aisanov, Zaurbek ^g   Oh, Yeon Mok ^h   Davis, Kourtney J ⁱ  

^a World wide Epidemiology   (United Kingdom)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Pulmonology Research Institute   (Russian Federation)

^h University of Ulsan College of Medicine   (South Korea)

ⁱ Worldwide Epidemiology Glaxosmithkline   (Belgium)

Author keywords

Chronic obstructive pulmonary disease; Patient perspective; Patient reported outcomes; Prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BRAZIL; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COPD ASSESSMENT TEST; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; FRANCE; GERMANY; HEALTH CARE UTILIZATION; HUMAN; ITALY; JAPAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MEXICO; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; NETHERLANDS; PREVALENCE; RATING SCALE; RUSSIAN FEDERATION; SEX RATIO; SMOKING; SOUTH KOREA; SPAIN; UNITED KINGDOM; UNITED STATES; AGE; AGED; CLINICAL TRIAL; EUROPE; HEALTH SURVEY; MIDDLE AGED; MULTICENTER STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; TIME;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BRAZIL; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REPUBLIC OF KOREA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 84902379402     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S61854     Document Type: Article

References (45)

1. Global initiative for chronic Obstructive Lung disease. Global Strategy for Diagnosis, Management, and Prevention of COPD. Bethesda (MD): GOLD; 2013. Available from: http://www.goldcopd.org/uploads/users/fles/GOLD_Report_2013_Feb20.pdf. Accessed October 30, 2013.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
3. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27: 397-412.
4. Cully JA, Graham D P, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics. 2006;47:312-319.
5. Carrasco Garrido P, Díez J, Gutiérrez J, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients: results of the EPIDEPOC study. Health Qual Life Outcomes. 2006;4:31.
6. Vermeire P. The burden of chronic obstructive pulmonary disease. Respir Med. 2002;96 Suppl C:S3-S10.
7. Miravitlles M, Ferrer M, Pont À, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59:387-395.
8. Donaldson GC, Wilkinson TM, Hurst JR, Perera WR, Wedzicha JA. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:446-452.
9. Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58:100-105.
10. Soler-Cataluña JJ, Martinez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925-931.
11. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012,67:957-963.
12. Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003;97 Suppl C:S3-S14.
13. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523-532.
14. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370:741-750.
15. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in fve Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875-1881.
16. Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002;20:799-805.
17. Uzaslan E, Mahboub B, Beji M, et al. The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106 Suppl 2:S45-S59.
18. Polatli M, Kheder AB, Wali S, et al. Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study. Respir Med. 2012; 106 Suppl 22:S75-S85.
19. Fletcher MJ, Upton J, Taylor-Fishwick J, et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health. 2011;11:612.
20. Barnes N, Calverley PM, Kaplan A, Rabe KF. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med. 2013;13:54.
21. CIBA Guest Symposium. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. Thorax. 1959;14:286-299.
22. American Thoracic Society Committee on Diagnostic Standards. Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis. 1962;85:762-769.
23. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproduc-ibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4:353-365.
24. Jones P W, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648-654.
25. Bestall JC, Paul EA, Garrod R, Garnham R, Jones P W, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-586.
26. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
27. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Research. 2005;40:1918-1930.
28. Jones P, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med. 2011;11:42.
29. [No authors listed]. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser. 2000;894:1-12, 1-253.
30. Ichinose M, Hisamichi A, Ishizaka A, et al. Chronic obstructive pulmonary disease (COPD) burden in Japan - confronting COPD Japan survey. Nihon Kokyuki Gakkai Zasshi. 2007;45:927-935. Japanese.
31. Menezes AM, Victora CG, Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population based study. Thorax. 1994;49:1217-1221.
32. Yo o KH, Kim YS, Sheen SS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology. 2011;16:659-665.
33. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004;9:458-465.
34. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013;143:1395-1406.
35. Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med. 2011;9:7.
36. Hagstad S, Ekerljung L, Lindberg A, Backman H, Rönmark E, Lundbäck B. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med. 2012;106: 980-988.
37. Zeng G, Sun B, Zhong N. Non-smoking-related chronic obstructive pulmonary disease: a neglected entity? Respirology. 2012;17:908-012.
38. Lopez A, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease and Risk Factors. Washington: World Bank; 2006.
39. Martinez FD. The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc. 2009;6:272-277.
40. Arbex MA, de Souza Conceição GM, Cendon S P, et al. Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits. J Epidemiol Community Health. 2009;63: 777-783.
41. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-807.
42. Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863-868.
43. Fukuhara S, Nishimura M, Nordyke RJ, Zaher CA, Peabody J W. Patterns of care for COPD by Japanese physicians. Respirology. 2005;10: 341-348.
44. Kim SR, Rhee YK. Overlap between asthma and COPD: where the two diseases converge. Allergy Asthma Immunol Res. 2010;2: 209-214.
45. Melbye H, Drivenes E, Dalbak LG, Leinan T, Høegh-Henrichsen S, Ostrem A. Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis. 2011;6:597-603.